A Contemporary Overview of PPARalpha/gamma Dual Agonists for the Management of Diabetic Dyslipidemia.
BACKGROUND: Diabetes mellitus and concomitant dyslipidemia, being referred to as 'diabetic dyslipidemia', are the foremost detrimental factors documented to play a pivotal role in cardiovascular illness. Diabetic dyslipidemia is associated with insulin re.....